Up to now, there is a net outflow of 31,528 billion dollars of main capital today; there is a net inflow of 31,528 billion dollars in the pharmaceutical-biological sector, with a net inflow of 1,522 billion dollars in the pharmaceutical-biological sector; the net outflow from the transferable securities sector, financing, and inclusion in FTSE Russell, etc., of which there is a net outflow of 30.189 billion yuan. In terms of individual stocks, Huanrui Century ranked first with net capital inflows of 346 million yuan, and Kweichow Moutai, N United Asia, and Shanghai Electric Power Co., Ltd. had the highest net capital inflows; Xinyisheng ranked first with net sales of 920 million yuan, and net outflows of Zhongji Xuchuang, Changxin Technology, and Cambrian Technology ranked first.
Zhitongcaijing · 4d ago
Share
Listen to the news
Up to now, there is a net outflow of 31,528 billion dollars of main capital today; there is a net inflow of 31,528 billion dollars in the pharmaceutical-biological sector, with a net inflow of 1,522 billion dollars in the pharmaceutical-biological sector; the net outflow from the transferable securities sector, financing, and inclusion in FTSE Russell, etc., of which there is a net outflow of 30.189 billion yuan. In terms of individual stocks, Huanrui Century ranked first with net capital inflows of 346 million yuan, and Kweichow Moutai, N United Asia, and Shanghai Electric Power Co., Ltd. had the highest net capital inflows; Xinyisheng ranked first with net sales of 920 million yuan, and net outflows of Zhongji Xuchuang, Changxin Technology, and Cambrian Technology ranked first.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending